Sabra Health Care Shareholders Approve Deal With Care Capital Properties
16 August 2017 - 8:50AM
Dow Jones News
By Esther Fung
Shareholders of Sabra Health Care REIT on Tuesday voted in favor
of a proposed merger with another skilled nursing company, Care
Capital Properties Inc., despite a backlash from investors that
threatened to derail the deal.
Some Sabra shareholders, including hedge funds Eminence Capital
LLC and Hudson Bay Capital Management LP, which own 3.9% and 3.4%
of the real-estate investment trust, respectively, had argued
against the proposed merger.
Sabra, based in Irvine, Calif., said the two shareholders
offered no strategic alternative that would benefit shareholders
over the long term and questioned whether they had the long-term
interests of the REIT in mind.
"In the near-term, we believe this transaction achieves our long
stated goals while providing us with a stronger platform for
continued growth," Sabra said in a statement on Tuesday after the
deal passed a shareholder vote by winning more than two-thirds of
the votes.
Both hedge funds in July released open letters questioning the
deal, arguing that a major tenant of Care Capital, Signature
Healthcare, is going through financial distress and could file for
bankruptcy protection. Eminence Capital and Hudson Bay Capital
didn't immediately respond to a request for comment.
Shares of Sabra have fallen 19% since the company announced on
May 7 it was planning a merger with Care Capital, a Chicago-based
skilled nursing REIT that had been spun out from Ventas Inc. in
2015. Shares of Care Capital initially rose but have declined by
around 11% since the announcement.
Hudson Bay also has said Sabra Chief Executive Richard Matros'
incentives aren't aligned with shareholders' interests, and that
the proposed deal could cause Mr. Matros's compensation to increase
by an estimated 37%.
"We believe that Mr. Matros's annual bonus compensation
structure is set up in a manner to potentially perversely
incentivize him to do transactions like this one, which are focused
on maximizing his annual bonus rather than maximizing shareholder
value," said Hudson Bay in a letter to Sabra's shareholders in late
July.
Sabra has said its management team's interests are directly
aligned with all of its shareholders.
Sabra refuted the hedge funds' criticisms of the economics of
the deal, arguing that combining with Care Capital diversifies its
tenant base, reduces its concentration from its top five tenants,
increases scale and improves its access to debt markets.
Changes to medical billing practices are contributing to shorter
lengths of stay and lower rates, which have been weighing on
operators of skilled nursing facilities. Many health care REITs,
including Sabra, earlier had reduced their exposure to the group to
focus on more profitable senior housing and medical office
buildings.
Proxy advisory firm Institutional Shareholder Services Inc.
recommended that shareholders vote against the deal, while advisers
Egan-Jones Proxy Services and Glass Lewis & Co. recommended
shareholders vote for the deal.
Glass Lewis argued that the short term nature of the positions
held by Hudson Bay and Eminence as well as a lack of alternative
strategy for long-term value creation raised questions over whether
the motivations of the new investors and their interests are
aligned with the long-term interests of the company and other
shareholders. Eminence started investing in Sabra in May while
Hudson Bay Capital invested in June.
At the announcement of the deal in May 7, Sabra said the merger
would create a $7.4 billion company that would make it
investment-grade and provide greater access to debt markets. The
transaction is scheduled to close on Aug. 17.
Write to Esther Fung at esther.fung@wsj.com
(END) Dow Jones Newswires
August 15, 2017 18:35 ET (22:35 GMT)
Copyright (c) 2017 Dow Jones & Company, Inc.
Care Capital Properties, Inc. (delisted) (NYSE:CCP)
Historical Stock Chart
From Dec 2024 to Jan 2025
Care Capital Properties, Inc. (delisted) (NYSE:CCP)
Historical Stock Chart
From Jan 2024 to Jan 2025